ASX - By Stock
|
CNB |
Re:
Ann: Intrusion Hosted Gold Up To 3.2 g/t Intersected at Strelley
|
|
Fyfee
|
138 |
46K |
27 |
05/05/21 |
05/05/21 |
ASX - By Stock
|
138
|
46K
|
27
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology $3 Milestone Cycling Gear
|
|
Fyfee
|
221 |
65K |
6 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
221
|
65K
|
6
|
|
Charts
|
EMR |
Re:
EMR - chart thread
|
|
Fyfee
|
73 |
37K |
12 |
30/04/21 |
30/04/21 |
Charts
|
73
|
37K
|
12
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Okvau Gold Project On Track For Commissioning 2Q21
|
|
Fyfee
|
58 |
25K |
7 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
58
|
25K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology $3 Milestone Cycling Gear
|
|
Fyfee
|
221 |
65K |
3 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
221
|
65K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology $3 Milestone Cycling Gear
|
|
Fyfee
|
221 |
65K |
4 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
221
|
65K
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
6 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
21K
|
7.3M
|
6
|
|
ASX - By Stock
|
EMR |
Re:
price
|
|
Fyfee
|
11 |
3.4K |
7 |
23/03/21 |
23/03/21 |
ASX - By Stock
|
11
|
3.4K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Change in substantial holding
|
|
Fyfee
|
185 |
54K |
6 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
185
|
54K
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
19 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
21K
|
7.3M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Oncology - Pharma Deals News
|
|
Fyfee
|
220 |
73K |
3 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
220
|
73K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Oncology - Pharma Deals News
|
|
Fyfee
|
220 |
73K |
15 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
220
|
73K
|
15
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
7 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
21K
|
7.3M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
I have just realised why RAC has skyrocketed
|
|
Fyfee
|
76 |
26K |
3 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
76
|
26K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology $3 Milestone Cycling Gear
|
|
Fyfee
|
221 |
65K |
3 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
221
|
65K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology $3 Milestone Cycling Gear
|
|
Fyfee
|
221 |
65K |
4 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
221
|
65K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology $3 Milestone Cycling Gear
|
|
Fyfee
|
221 |
65K |
21 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
221
|
65K
|
21
|
|
ASX - By Stock
|
RAC |
Re:
Race Oncology $3 Milestone Cycling Gear
|
|
Fyfee
|
221 |
65K |
7 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
221
|
65K
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
33 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
21K
|
7.3M
|
33
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
26 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
21K
|
7.3M
|
26
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
62 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
21K
|
7.3M
|
62
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
122 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
21K
|
7.3M
|
122
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
8 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
21K
|
7.3M
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Fyfee
|
21K |
7.3M |
2 |
22/01/21 |
22/01/21 |
ASX - By Stock
|
21K
|
7.3M
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Charts & Broker Data
|
|
Fyfee
|
2.0K |
738K |
14 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
2.0K
|
738K
|
14
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Annual General Meeting - Chairman's Address
|
|
Fyfee
|
19 |
6.5K |
4 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
19
|
6.5K
|
4
|
|
ASX - By Stock
|
CNB |
Re:
Charts & Broker Data
|
|
Fyfee
|
2.0K |
738K |
1 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
2.0K
|
738K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Huge overhang of potential sellers here
|
|
Fyfee
|
32 |
8.3K |
18 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
32
|
8.3K
|
18
|
|
ASX - By Stock
|
CNB |
Re:
Charts & Broker Data
|
|
Fyfee
|
2.0K |
738K |
2 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
2.0K
|
738K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
2 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
3.5K
|
972K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
3 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
3.5K
|
972K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
3 |
03/12/20 |
03/12/20 |
ASX - By Stock
|
3.5K
|
972K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
22 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
3.5K
|
972K
|
22
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
4 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
3.5K
|
972K
|
4
|
|
ASX - By Stock
|
CNB |
Re:
Charts & Broker Data
|
|
Fyfee
|
2.0K |
738K |
3 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
2.0K
|
738K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
Charts & Broker Data
|
|
Fyfee
|
2.0K |
738K |
8 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
2.0K
|
738K
|
8
|
|
ASX - By Stock
|
CNB |
Re:
Charts & Broker Data
|
|
Fyfee
|
2.0K |
738K |
1 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
2.0K
|
738K
|
1
|
|
ASX - By Stock
|
CNB |
Re:
Charts & Broker Data
|
|
Fyfee
|
2.0K |
738K |
7 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
2.0K
|
738K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Preclinical Bisantrene Breast Cancer Results
|
|
Fyfee
|
222 |
56K |
43 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
222
|
56K
|
43
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Annual General Meeting - Chairman's Address
|
|
Fyfee
|
19 |
6.5K |
21 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
19
|
6.5K
|
21
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
40 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
3.5K
|
972K
|
40
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
8 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
3.5K
|
972K
|
8
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
3 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
3.5K
|
972K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
CNB Summary and Why Its So Undervalued
|
|
Fyfee
|
3.5K |
972K |
8 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
3.5K
|
972K
|
8
|
|
ASX - By Stock
|
CNB |
Re:
Can we all agree?
|
|
Fyfee
|
159 |
39K |
4 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
159
|
39K
|
4
|
|
ASX - By Stock
|
CNB |
Re:
Can we all agree?
|
|
Fyfee
|
159 |
39K |
2 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
159
|
39K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Can we all agree?
|
|
Fyfee
|
159 |
39K |
2 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
159
|
39K
|
2
|
|
ASX - By Stock
|
CNB |
Re:
Can we all agree?
|
|
Fyfee
|
159 |
39K |
4 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
159
|
39K
|
4
|
|
ASX - By Stock
|
CNB |
Re:
Can we all agree?
|
|
Fyfee
|
159 |
39K |
1 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
159
|
39K
|
1
|
|
ASX - By Stock
|
CNB |
Re:
Can we all agree?
|
|
Fyfee
|
159 |
39K |
4 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
159
|
39K
|
4
|
|